CILOXAN 3 mg/ml, solution ear drops bottle, 5 ml
Active ingredients: Ciprofloxacin hydrochloride, Ciprofloxacin
Commercialized according to BDPMDispensing in France: Prescription only
Solution for instillationbottle, 5 mlauriculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CILOXAN 3 mg/ml, solution pour instillation auriculaire
- Pharmaceutical form
- solution pour instillation
- Route of administration
- auriculaire
- Presentation description
- 1 flacon(s) polyéthylène basse densité (PEBD) de 5 ml
- Marketing authorisation holder
- NOVARTIS PHARMA
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 12 Sept 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67901977CIP73601303CIP133400936013032Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CIPROFLOXACINEsolution | 3 mg · 1 ml | FT |
| CHLORHYDRATE DE CIPROFLOXACINEsolution | 3,5 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.